1. Home
  2. GNSS vs NVNO Comparison

GNSS vs NVNO Comparison

Compare GNSS & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNSS
  • NVNO
  • Stock Information
  • Founded
  • GNSS 1992
  • NVNO 1987
  • Country
  • GNSS United States
  • NVNO United States
  • Employees
  • GNSS N/A
  • NVNO N/A
  • Industry
  • GNSS Consumer Electronics/Appliances
  • NVNO Medical/Dental Instruments
  • Sector
  • GNSS Consumer Staples
  • NVNO Health Care
  • Exchange
  • GNSS Nasdaq
  • NVNO Nasdaq
  • Market Cap
  • GNSS 78.1M
  • NVNO 71.0M
  • IPO Year
  • GNSS N/A
  • NVNO N/A
  • Fundamental
  • Price
  • GNSS $1.96
  • NVNO $4.20
  • Analyst Decision
  • GNSS Strong Buy
  • NVNO
  • Analyst Count
  • GNSS 3
  • NVNO 0
  • Target Price
  • GNSS $5.33
  • NVNO N/A
  • AVG Volume (30 Days)
  • GNSS 131.5K
  • NVNO 93.8K
  • Earning Date
  • GNSS 08-05-2025
  • NVNO 07-30-2025
  • Dividend Yield
  • GNSS N/A
  • NVNO N/A
  • EPS Growth
  • GNSS N/A
  • NVNO N/A
  • EPS
  • GNSS N/A
  • NVNO N/A
  • Revenue
  • GNSS $27,780,000.00
  • NVNO N/A
  • Revenue This Year
  • GNSS $91.14
  • NVNO N/A
  • Revenue Next Year
  • GNSS $75.44
  • NVNO N/A
  • P/E Ratio
  • GNSS N/A
  • NVNO N/A
  • Revenue Growth
  • GNSS N/A
  • NVNO N/A
  • 52 Week Low
  • GNSS $1.46
  • NVNO $2.03
  • 52 Week High
  • GNSS $4.04
  • NVNO $6.48
  • Technical
  • Relative Strength Index (RSI)
  • GNSS 70.78
  • NVNO 59.82
  • Support Level
  • GNSS $1.48
  • NVNO $3.89
  • Resistance Level
  • GNSS $1.85
  • NVNO $4.40
  • Average True Range (ATR)
  • GNSS 0.10
  • NVNO 0.24
  • MACD
  • GNSS 0.05
  • NVNO -0.02
  • Stochastic Oscillator
  • GNSS 98.11
  • NVNO 64.06

About GNSS Genasys Inc.

Genasys Inc is a provider of Protective Communication solutions, including Genasys Protect software platform and Long Range Acoustic Device (LRAD). Its software platform receives information from variety of sensors and Internet-of-Things (IoT) inputs to collect real-time information on developing and active emergency situations. Genasys uses this information to create and disseminate alerts, warnings, notifications, and instructions through multiple channels before, during, and after public safety and enterprise threats, critical events, and other crisis situations. The Company operates in two business segments: Hardware and Software and its markets are North and South America, Europe, Middle East and Asia. Key revenue is generated from Hardware.

About NVNO enVVeno Medical Corporation

enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.

Share on Social Networks: